Literature DB >> 12100896

The control of neural stem cells by morphogenic signals.

David M Panchision1, Ronald D G McKay.   

Abstract

A complex orchestration of stem-cell specification, expansion and differentiation is required for the proper development of the nervous system. Although progress has been made on the role of individual genes in each of these processes, there are still unresolved questions about how gene function translates to the dynamic assembly of cells into tissues. Recently, stem-cell biology has emerged as a bridge between the traditional fields of cell biology and developmental genetics. In addition to their potential therapeutic role, stem cells are being exploited as experimental 'logic chips' that integrate information and exhibit self-organizing properties. Recent studies provide new insights on how morphogenic signals coordinate major stem cell decisions to regulate the size, shape and cellular diversity of the nervous system.

Mesh:

Substances:

Year:  2002        PMID: 12100896     DOI: 10.1016/s0959-437x(02)00329-5

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  46 in total

Review 1.  Neural stem cells redefined: a FACS perspective.

Authors:  Dragan Maric; Jeffery L Barker
Journal:  Mol Neurobiol       Date:  2004-08       Impact factor: 5.590

2.  Conversion of myoblasts to physiologically active neuronal phenotype.

Authors:  Yumi Watanabe; Sei Kameoka; Vidya Gopalakrishnan; Kenneth D Aldape; Zhizhong Z Pan; Frederick F Lang; Sadhan Majumder
Journal:  Genes Dev       Date:  2004-04-12       Impact factor: 11.361

3.  PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas.

Authors:  Hongwu Zheng; Haoqiang Ying; Ruprecht Wiedemeyer; Haiyan Yan; Steven N Quayle; Elena V Ivanova; Ji-Hye Paik; Hailei Zhang; Yonghong Xiao; Samuel R Perry; Jian Hu; Anant Vinjamoori; Boyi Gan; Ergun Sahin; Milan G Chheda; Cameron Brennan; Y Alan Wang; William C Hahn; Lynda Chin; Ronald A DePinho
Journal:  Cancer Cell       Date:  2010-05-18       Impact factor: 31.743

4.  Expression of hyaluronan and the hyaluronan-binding proteoglycans neurocan, aggrecan, and versican by neural stem cells and neural cells derived from embryonic stem cells.

Authors:  Mary Abaskharoun; Marie Bellemare; Elizabeth Lau; Richard U Margolis
Journal:  Brain Res       Date:  2010-02-20       Impact factor: 3.252

5.  Krüppel-like family of transcription factor 9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cells.

Authors:  Mingyao Ying; Yingying Sang; Yunqing Li; Hugo Guerrero-Cazares; Alfredo Quinones-Hinojosa; Angelo L Vescovi; Charles G Eberhart; Shuli Xia; John Laterra
Journal:  Stem Cells       Date:  2011-01       Impact factor: 6.277

6.  Complementary roles for histone deacetylases 1, 2, and 3 in differentiation of pluripotent stem cells.

Authors:  Glen W Humphrey; Yong-Hong Wang; Tazuko Hirai; Raji Padmanabhan; David M Panchision; Laura F Newell; Ronald D G McKay; Bruce H Howard
Journal:  Differentiation       Date:  2007-11-15       Impact factor: 3.880

Review 7.  Growth factors improve neurogenesis and outcome after focal cerebral ischemia.

Authors:  Ronen Robert Leker; Valeri Lasri; David Chernoguz
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575

8.  Overexpression of basic helix-loop-helix transcription factors enhances neuronal differentiation of fetal human neural progenitor cells in various ways.

Authors:  Angéline Serre; Evan Y Snyder; Jacques Mallet; Delphine Buchet
Journal:  Stem Cells Dev       Date:  2011-07-18       Impact factor: 3.272

Review 9.  Beyond TGFβ: roles of other TGFβ superfamily members in cancer.

Authors:  Lalage M Wakefield; Caroline S Hill
Journal:  Nat Rev Cancer       Date:  2013-05       Impact factor: 60.716

Review 10.  Tumor initiating cells in malignant gliomas: biology and implications for therapy.

Authors:  Costas G Hadjipanayis; Erwin G Van Meir
Journal:  J Mol Med (Berl)       Date:  2009-02-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.